Non Invasive Prenatal Testing Market

Non Invasive Prenatal Testing Market Size, Share, Growth Analysis, By Gestation Period(0-12 Weeks, 13-24 Weeks), By Pregnancy Risk(High & Average Risk, Low Risk), By Method(Ultrasound Detection, Biochemical Screening Tests), By Technology(NGS, Array Technology), By Product(Consumables & Reagents, Instruments), By Application(Trisomy, Microdeletion Syndrome), By End-use(Hospitals & Clinics, Diagnostic Laboratories), By Regional(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35A2459 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Regional Analysis:

Non Invasive Prenatal Testing Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.

Non Invasive Prenatal Testing Market Attractiveness Analysis, By Region 2020-2028
AttractivenessAnalysis
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Non Invasive Prenatal Testing was estimated to be valued at US$ XX Mn in 2021.

The Non Invasive Prenatal Testing Market is estimated to grow at a CAGR of XX% by 2028.

The Non Invasive Prenatal Testing Market is segmented on the basis of Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Regional.

Based on region, the Non Invasive Prenatal Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Non Invasive Prenatal Testing Market are Genesis Genetics (CooperSurgical, Inc.), Natera, Inc., Centogene N.V., Illumina, Inc. (Verinata Health, Inc.), Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics), Myriad Women’s Health, Inc. (Counsyl, Inc.), Progenity, Inc., Qiagen, Laboratory Corp. of America Holdings, Quest Diagnostics, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Non Invasive Prenatal Testing Market

Product ID: UCMIG35A2459

$5,300
BUY NOW GET FREE SAMPLE